SR 31742A

Drug Profile

SR 31742A

Alternative Names: SR 31742

Latest Information Update: 09 Mar 2001

Price : $50

At a glance

  • Originator Sanofi-Synthelabo
  • Class Antipsychotics
  • Mechanism of Action Sigma receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Manic episodes; Schizophrenia

Most Recent Events

  • 09 Mar 2001 Discontinued-II for Schizophrenia in USA (Unknown route)
  • 09 Mar 2001 Discontinued-II for Schizophrenia in France (Unknown route)
  • 09 Mar 2001 Discontinued-II for Manic episodes in France (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top